A Novel First-line Calcium Channel Blocker for Hypertension Management
COMPOSITION – Cilnidipine IP 10 mg
Researchers recommend Cilnidipine as a novel first-line CCB for the management of hypertension either as a monotherapy or as a combination therapy. Cilnidipine is highly lipophilic and shows low BP variability among CCBs. The organ protection, especially the reno-protective effect of Cilnidipine deserves special attention.
- Class of medications: Calcium channel blockers
>It is a new antihypertensive drug distinguished from other L-type Ca2+ channel blockers.
> More effective than amlodipine at improving renal function and arterial stiffness in patients with essential.
>Has an anti-proteinuric effect especially in patients with essential hypertension.
> Treats mild to moderate essential hypertension.
Cilnidipine IP 10 mg
- Cilnidipine is expected to be favorable for various types of complications of hypertension.